ESC 365 - Doctor Kieran Docherty

Speaker illustration

Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

Heart Failure Association

Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: SGLT2 inhibitors: pearls from recent trials and surveys

The effect of dapagliflozin according to iron status and its effect on iron metabolism: insights from DAPA-HF

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Young Investigator Award: clinical research

Fast conducting atrial fibrillation and newly diagnosed heart failure.

Event: Heart Failure 2022

Topic: Atrial Fibrillation (AF)

Session: Atrial fibrillation

The effect of dapagliflozin across the spectrum of baseline risk: a post-hoc analysis of DAPA-HF

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure ePosters

Declining risk of heart failure hospitalisation following first acute myocardial infarction in Scotland between 1990-2015

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Real world heart failures populations

ESC 365 is supported by